| P50 | author | Munir Pirmohamed | Q20127995 |
| P2093 | author name string | Olga Vasieva | |
| | Anthony Guy Marson | |
| | Nasir Mirza | |
| P2860 | cites work | Identifying biological themes within lists of genes with EASE | Q24630875 |
| | Identification of interferon-modulated proliferation-related cDNA sequences | Q24632292 |
| | Membrane fusion: grappling with SNARE and SM proteins | Q24633113 |
| | Binding of the synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-25, can explain docked vesicles at neurotoxin-treated synapses | Q24671842 |
| | The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules | Q28118665 |
| | Ca2+-dependent synaptotagmin binding to SNAP-25 is essential for Ca2+-triggered exocytosis | Q28204182 |
| | Synaptotagmin: a Ca(2+) sensor that triggers exocytosis? | Q28208303 |
| | The neurobiology of antiepileptic drugs | Q28267900 |
| | The emerging role for chemokines in epilepsy | Q28285051 |
| | IQ-motif proteins influence intracellular free Ca2+ in hippocampal neurons through their interactions with calmodulin | Q28580789 |
| | A role for leukocyte-endothelial adhesion mechanisms in epilepsy | Q30488791 |
| | Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulation | Q30840230 |
| | Aquaporin-4 is increased in the sclerotic hippocampus in human temporal lobe epilepsy | Q30974448 |
| | Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. | Q31146509 |
| | Serial analysis of gene expression in the hippocampus of patients with mesial temporal lobe epilepsy. | Q33231634 |
| | Global expression profiling in epileptogenesis: does it add to the confusion? | Q33588199 |
| | Characterization, using comparative proteomics, of differentially expressed proteins in the hippocampus of the mesial temporal lobe of epileptic rats following treatment with valproate | Q33594540 |
| | How does calcium trigger neurotransmitter release? | Q33950706 |
| | Endogenous SNAP-25 regulates native voltage-gated calcium channels in glutamatergic neurons | Q34042778 |
| | Seizure-promoting effect of blood-brain barrier disruption | Q34056074 |
| | Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus. | Q34092030 |
| | The natural history of epilepsy in the era of new antiepileptic drugs and surgical treatment | Q34173963 |
| | Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. | Q34346791 |
| | Cholecystokinin: a multi-functional molecular switch of neuronal circuits | Q34420892 |
| | TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis | Q34583749 |
| | Animal models of drug-resistant epilepsy | Q34624849 |
| | Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity | Q34997364 |
| | Fibroblast growth factors and neuroprotection | Q35063088 |
| | TGF-betas and their roles in the regulation of neuron survival | Q35063091 |
| | A Greater Role for Surgical Treatment of Epilepsy: Why and When? | Q35537454 |
| | Large-scale analysis of gene expression in epilepsy research: is synthesis already possible? | Q35791557 |
| | Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes | Q35795750 |
| | Integrins, synaptic plasticity and epileptogenesis. | Q35834535 |
| | Brain inflammation in epilepsy: experimental and clinical evidence | Q36319367 |
| | Elevated p53 and lower MDM2 expression in hippocampus from patients with intractable temporal lobe epilepsy | Q36389556 |
| | Intrinsic severity as a determinant of antiepileptic drug refractoriness | Q36934796 |
| | ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy | Q36957955 |
| | Stabilizing dendritic structure as a novel therapeutic approach for epilepsy | Q37174044 |
| | Neurogenesis in the human hippocampus and its relevance to temporal lobe epilepsies. | Q37181313 |
| | One of the hottest topics in epileptology: ABC proteins. Their inhibition may be the future for patients with intractable seizures | Q37204397 |
| | The clinical impact of pharmacogenetics on the treatment of epilepsy | Q37216732 |
| | Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population | Q37399443 |
| | The mechanisms of medically refractory temporal lobe epilepsy | Q37644434 |
| | SLC22 transporter family proteins as targets for cytostatic uptake into tumor cells | Q37824862 |
| | Overexpression of N-WASP in the brain of human epilepsy | Q38288229 |
| | Effect of prolonged phenytoin administration on rat brain gene expression assessed by DNA microarrays. | Q38344749 |
| | Possible role of the innate immunity in temporal lobe epilepsy. | Q38514811 |
| | New developments in antiepileptic drug resistance: an integrative view | Q39981787 |
| | Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis | Q40339152 |
| | The epidemiology and treatment of chronic and refractory epilepsy | Q40993427 |
| | Alterations in cholecystokinin peptide and mRNA in actively epileptic human temporal cortical foci | Q41188998 |
| | Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptides and their fragments in rats after intracerebroventricular administration | Q42240437 |
| | Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a 'two-hit' seizure model. | Q42549162 |
| | Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. | Q42681771 |
| | Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum | Q44014881 |
| | Spontaneous seizures and loss of axo-axonic and axo-somatic inhibition induced by repeated brief seizures in kindled rats. | Q44396237 |
| | Differential phosphorylation of syntaxin and synaptosome-associated protein of 25 kDa (SNAP-25) isoforms | Q44560610 |
| | Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy | Q44680410 |
| | Pharmacogenetic association study of 30 genes with phenobarbital drug response in epileptic dogs | Q44855938 |
| | Cholecystokinin-8 sulfate modulates the anticonvulsant efficacy of vigabatrin in an experimental model of partial complex epilepsy in the rat. | Q46120591 |
| | Carbamazepine protects against neuronal hyperplasia and abnormal gene expression in the megencephaly mouse | Q46387281 |
| | Antiepileptic drug resistant rats differ from drug responsive rats in GABA A receptor subunit expression in a model of temporal lobe epilepsy. | Q46533643 |
| | Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex. | Q46884649 |
| | Correlation of transcriptome profile with electrical activity in temporal lobe epilepsy | Q46946542 |
| | Upregulated expression of postsynaptic density-93 and N-methyl-D-aspartate receptors subunits 2B mRNA in temporal lobe tissue of epilepsy | Q48165983 |
| | Effect of CCK-8 on audiogenic epileptic seizure in P77PMC rats | Q48251727 |
| | Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy | Q48376563 |
| | Decreased expression of thyroid receptor-associated protein 220 in temporal lobe tissue of patients with refractory epilepsy | Q48436981 |
| | Suppression of audiogenic epileptic seizures by intracerebral injection of a CCK gene vector | Q48447794 |
| | Gene expression analysis on anterior temporal neocortex of patients with intractable epilepsy | Q48512146 |
| | Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression | Q48930548 |
| | The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediated. | Q50645121 |
| | Neurogranin/RC3 enhances long-term potentiation and learning by promoting calcium-mediated signaling. | Q51996138 |
| | Combining multiple microarray studies and modeling interstudy variation. | Q52012806 |
| | Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. | Q53574209 |
| | α5GABAA Receptors Regulate the Intrinsic Excitability of Mouse Hippocampal Pyramidal Neurons | Q60706586 |
| | Cholecystokinin blocks some effects of kainic acid in CA3 region of hippocampal slices | Q70193319 |
| | Gene expression profile analysis by DNA microarrays: promise and pitfalls | Q77180016 |
| | Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis | Q82354361 |
| | Complexin: does it deserve its name? | Q82820230 |
| P433 | issue | 22 | |
| P921 | main subject | neurosurgery | Q188449 |
| | brain tissue | Q11850260 |
| P304 | page(s) | 4381-4394 | |
| P577 | publication date | 2011-08-18 | |
| P1433 | published in | Human Molecular Genetics | Q2720965 |
| P1476 | title | Exploring the genomic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgery | |
| P478 | volume | 20 | |